US2003096717A1PendingUtilityA1
Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
Est. expiryAug 17, 2021(expired)· nominal 20-yr term from priority
A61L 12/141A61L 12/142
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method for inhibiting the binding of a biguanide antimicrobial in aqueous solution to a hydrogel in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit sorption of the biguanide antimicrobial to a hydrogel.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method for inhibiting the binding of a biguanide antimicrobial in aqueous solution to a hydrogel in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit binding of the biguanide antimicrobial to the hydrogel.
2 . The method of claim 1 wherein the biguanide antimicrobial is selected from the group consisting of poly(hexamethylene) biguanide and alexidine.
3 . The method of claim 1 wherein said hydrogel is a silicone hydrogel.
4 . The method of claim 1 wherein said solution further comprises at least one buffer.
5 . The method of claim 1 wherein said solution further comprises at least one chelating agent or sequestering agent.
6 . The method of claim 1 wherein said solution further comprises at least one tonicity adjusting agent.
7 . The method of claim 1 wherein said solution further comprises at least one surfactant.
8 . The method of claim 1 wherein said solution comprises at least one pH adjusting agent.
9 . The method of claim 1 wherein said solution comprises at least one viscosity builder.
10 . The method of claim 1 wherein said solution comprises from about 0.0001 to about 10 weight percent cyclodextrin.
11 . The method of claim 10 wherein said solution comprises from about 0.01 to about 2.0 weight percent cyclodextrin.
12 . A composition for rewetting, disinfecting and/or cleaning contact lenses comprising at least one biguanide antimicrobial and an amount of cyclodextrin that is insufficient of itself to effectively clean contact lenses if that amount of cyclodextrin were present in the solution in the absence of at least one other cleaning agent.
13 . The composition of claim 12 wherein the biguanide antimicrobial is selected from the group consisting of poly(hexamethylene) biguanide and alexidine.
14 . The method of claim 12 wherein said solution further comprises at least one buffer.
15 . The method of claim 12 wherein said solution further comprises at least one chelating agent or sequestering agent.
16 . The method of claim 12 wherein said solution further comprises at least one tonicity adjusting agent.
17 . The composition of claim 12 wherein said aqueous solution further comprises buffers, chelating and/or sequestering agents, tonicity adjusting agents, surfactants, pH adjusting agents and viscosity builders.
18 . The composition of claim 12 wherein said solution comprises from about 0.0001 to about 10 weight percent cyclodextrin.
19 . The composition of claim 18 wherein said solution comprises from about 0.01 to about 2.0 weight percent cyclodextrin.
20 . The composition of claim 12 wherein said amount of cyclodextrin is at least sufficient to inhibit sorption of a biguanide antimicrobial to said contact lenses.Join the waitlist — get patent alerts
Track US2003096717A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.